i
Trends in the use of active surveillance and treatments in Medicare beneficiaries diagnosed with localized prostate cancer
-
7 2021
Source: Urol Oncol. 39(7):432.e1-432.e10 -
Alternative Title:Urol Oncol
-
Personal Author:
-
Description:Background:
The treatment for men diagnosed with localized prostate cancer has changed over time given the increased attention to the harms associated with over-diagnosis and the development of protocols for active surveillance.
Methods:
We examined trends in the treatment of men diagnosed with localized prostate cancer between 2004 and 2015, using the most recently available data from Surveillance, Epidemiology, and End Results Program (SEER)-Medicare. Patients were stratified by Gleason score, age, and race groups.
Results:
The use of active surveillance increased from 22% in 2004–2005 to 50% in 2014–2015 for patients with a Gleason score of 6 or below and increased from 9% in 2004–2005 to 13% in 2014–2015 for patients with a Gleason score of 7 or above. Patients with a Gleason score of 7 or above had increased use of intensity-modulated radiation therapy and prostatectomy, especially among patients aged 75 years and older. Among patients with a Gleason score of 6 or below non-Hispanic black men were less likely to undergo active surveillance than non-Hispanic white men.
Conclusions:
There has been a large increase in the use of active surveillance among men with a Gleason score of 6 or below. However, non-Hispanic black men with a Gleason score of 6 or below are less likely to receive active surveillance.
-
Subjects:
-
Keywords:
-
Source:
-
Pubmed ID:33308973
-
Pubmed Central ID:PMC8374746
-
Document Type:
-
Funding:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
-
xml pdf docx gif jpeg gif jpeg gif jpeg gif jpeg
Details:
Supporting Files
More +